Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 205-214

  Csaba, Noemi ^a   Köping Höggård, Magnus ^a   Alonso, Maria Jose ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chitosan; Gene delivery; Ionic gelation; Nanoparticles; Oligonucleotides; pDNA

Indexed keywords

BETA GALACTOSIDASE; BOVINE SERUM ALBUMIN; CHITOSAN; DOUBLE STRANDED DNA; NANOPARTICLE; OLIGONUCLEOTIDE; PLASMID DNA; PROTASAN; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL STRAIN HEK293; CELL TRANSPORT; CONTROLLED STUDY; CROSS LINKING; DNA TRANSFECTION; DRUG FORMULATION; DRUG RELEASE; ENDOCYTOSIS; GELATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MOLECULAR WEIGHT; MOUSE; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL TRANSPORT; CELL LINE; CHITOSAN; CROSS-LINKING REAGENTS; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; NANOPARTICLES; OLIGONUCLEOTIDES; PLASMIDS; POLYPHOSPHATES; SERUM ALBUMIN, BOVINE; TIME FACTORS; TRANSFECTION;

EID: 70350208807     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.028     Document Type: Article

References (40)

1. Calvo P., Remunan-Lopez C., Vila-Jato J.L., and Alonso M.J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14 (1997) 1431-1436
2. Calvo P., Remunan-Lopez C., Vila Jato J.L., and Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63 (1997) 125-132
3. Csaba N., Caamano P., Sanchez A., Dominguez F., and Alonso M.J. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 6 (2005) 271-278
4. Csaba N., Koping-Hoggard M., Novoa-Carballal R., Fernandez-Megia E., Riguera R., and Alonso M.J. Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 71 (2009) 257-263
5. Cuna M., Alonso-Sandel M., Remunan-Lopez C., Pivel J.P., Alonso-Lebrero J.L., and Alonso M.J. Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J. Nanosci. Nanotechnol. 6 (2006) 2887-2895
6. Dang J.M., and Leong K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 58 (2006) 487-499
7. Danielsen S., Varum K.M., and Stokke B.T. Structural analysis of chitosan mediated DNA condensation by AFM: influence of chitosan molecular parameters. Biomacromolecules 5 (2004) 928-936
8. De Campos A.M., Diebold Y., Carvalho E.L., Sanchez A., and Alonso M.J. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm. Res. 21 (2004) 803-810
9. De La Fuente M., Seijo B., and Alonso M.J. Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Ther. 15 (2008) 668-676
10. De La Fuente M., Seijo B., and Alonso M.J. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 49 (2008) 2016-2024
11. Dung T.H., Lee S.R., Han S.D., Kim S.J., Ju Y.M., Kim, et al. Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment. J. Nanosci. Nanotechnol. 7 (2007) 3695-3699
12. Erbacher P., Zou S., Bettinger T., Steffan A.M., and Remy J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 15 (1998) 1332-1339
13. 1H-NMR. Carbohydr. Polym. 61 (2005) 155-161
14. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., and Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16 (1999) 1576-1581
15. Fernandez-Urrusuno R., Romani D., Calvo P., Vila Jato J.L., and Alonso M.J. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sci. 9 (1999) 429-436
16. Howard K.A., Paludan S.R., Behlke M.A., Besenbacher F., Deleuran B., and Kjems J. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. (2008)
17. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen, et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 14 (2006) 476-484
18. Ishii T., Okahata Y., and Sato T. Facile preparation of a fluorescence-labeled plasmid. Biochim. Biophys. Acta 1514 (2000) 51-64
19. Ishii T., Okahata Y., and Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514 (2001) 51-64
20. Janes K., and Alonso M.J. Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J. Appl. Polym. Sci. 12 (2003) 2769-2776
21. Kiang T., Bright C., Cheung C.Y., Stayton P.S., Hoffman A.S., and Leong K.W. Formulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expression. J. Biomater. Sci. Polym. Ed. 15 (2004) 1405-1421
22. Kim Y.H., Gihm S.H., Park C.R., Lee K.Y., Kim T.W., Kwon I.C., et al. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjug. Chem. 12 (2001) 932-938
23. Koping-Hoggard M., Mel'nikova Y.S., Varum K.M., Lindman B., and Artursson P. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J. Gene Med. 5 (2003) 130-141
24. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., et al. Chitosan as a nonviral gene delivery system, Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8 (2001) 1108-1121
25. Koping-Hoggard M., Varum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11 (2004) 1441-1452
26. Lamarque G., Lucas J.M., Viton C., and Domard A. Physicochemical behavior of homogeneous series of acetylated chitosans in aqueous solution: role of various structural parameters. Biomacromolecules 6 (2005) 131-142
27. Lee D., Zhang W., Shirley S.A., Kong X., Hellermann G.R., Lockey R.F., et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm. Res. 24 (2007) 157-167
28. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., and August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control Release 53 (1998) 183-193
29. Liu X., Howard K.A., Dong M., Andersen M.O., Rahbek U.L., Johnsen, et al. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28 (2007) 1280-1288
30. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., and Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 57 (2004) 1-8
31. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control Release 70 (2001) 399-421
32. Morille M., Passirani C., Vonarbourg A., Clavreul A., and Benoit J.P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29 (2008) 3477-3496
33. Qi L., Xu Z., Jiang X., Li Y., and Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg. Med. Chem. Lett. 15 (2005) 1397-1399
34. Romoren K., Pedersen S., Smistad G., Evensen O., and Thu B.J. The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. Int. J. Pharm. 261 (2003) 115-127
35. Sato T., Ishii T., and Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22 (2001) 2075-2080
36. Teijeiro-Osorio D., Remunan-Lopez C., and Alonso M.J. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur. J. Pharm. Biopharm. 71 (2009) 257-263
37. Vila A., Sanchez A., Tobio M., Calvo P., and Alonso M.J. Design of biodegradable particles for protein delivery. J. Control Release 78 (2002) 15-24
38. Yoo H.S., Lee J.E., Chung H., Kwon I.C., and Jeong S.Y. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J. Control Release 103 (2005) 235-243
39. Zhang H., Oh M., Allen C., and Kumacheva E. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 5 (2004) 2461-2468
40. Zhang X., Ercelen S., Duportail G., Schaub E., Tikhonov V., Slita A., et al. Hydrophobically modified low molecular weight chitosans as efficient and nontoxic gene delivery vectors. J. Gene Med. 10 (2008) 527-539